Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Sonova Holding AG is a Swiss company operating in the healthcare industry, specializing in hearing care solutions. The company offers a comprehensive range of products, including hearing aids, cochlear implants, and wireless communication systems. Founded in 1947 and headquartered in Stäfa, Switzerland, Sonova serves a global market, providing advanced hearing care technology and services. Its strategic positioning is strengthened by continuous innovation in audiological performance and customer-centric solutions, supported by proprietary technology and a strong distribution network through its own channels and third-party retailers.
View stock
VS
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stock

Stock highlights

Stock comparison highlights
Stock name
Sonova Holding AGAbbVie
Last price
CHF 279.20$283.74
Currency
CHF
USD
CHF 17B$504B
38.0180.63
CHF 7.22$3.54
1.070.28
CHF 4.70$6.83
1.71%2.42%
Sector
HealthHealth
Employees
18,58057,000
Ticker
Fr. SOON$ABBV
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.SOON or $ABBV on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.